Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors
Carmine Zoccali(Biogem), Yūji Matsuzawa(Sumitomo Hospital), Francesca Mallamaci(Società Italiana di Nefrologia), Noriyuki Ouchi(Nagoya University), Sebastiano Cutrupi(National Research Council), Shinji Kihara(University of Copenhagen), Sachiyo Tanaka(Nippon Veterinary and Life Science University), Saverio Parlongo(National Research Council), Tohru Funahashi(The University of Osaka), Giovanni Tripepi(National Research Council), Francesco Catalano(Osservatorio Astrofisico di Catania), Vincenzo Panuccio
Cited by 129
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k